Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fourquet

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 21, 2022
A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast CancersP Loap, B Nicaise, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 29, 2021
[Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results]I Chaffai, K Cao, M Kissel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2004
[Breast-conserving therapy of breast cancer]V Doridot, C Nos, J S Aucouturier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 3, 2021
Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literatureS Allali, F Chasset, Y Kirova, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
S-phase fractions of breast cancer predict overall and post-relapse survivalY Remvikos, V Mosseri, B Asselain, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-upA Fourquet, F Campana, B Zafrani, et al.
Journal of Cellular and Molecular Medicine|April 20, 2004
Topical superoxide dismutase reduces post-irradiation breast cancer fibrosisF Campana, S Zervoudis, B Perdereau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 10, 2013
[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]X Liem, C Chira, A Fourquet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 29, 2017
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicityZ Ajgal, S de Percin, V Diéras, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1995
Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trialA Fourquet, F Campana, V Mosseri, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 21, 2022
A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast CancersP Loap, B Nicaise, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 29, 2021
[Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results]I Chaffai, K Cao, M Kissel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2004
[Breast-conserving therapy of breast cancer]V Doridot, C Nos, J S Aucouturier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 3, 2021
Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literatureS Allali, F Chasset, Y Kirova, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
S-phase fractions of breast cancer predict overall and post-relapse survivalY Remvikos, V Mosseri, B Asselain, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1989
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-upA Fourquet, F Campana, B Zafrani, et al.
Journal of Cellular and Molecular Medicine|April 20, 2004
Topical superoxide dismutase reduces post-irradiation breast cancer fibrosisF Campana, S Zervoudis, B Perdereau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 10, 2013
[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]X Liem, C Chira, A Fourquet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 29, 2017
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicityZ Ajgal, S de Percin, V Diéras, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1995
Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trialA Fourquet, F Campana, V Mosseri, et al.
Pageof 17